4 headlines
Parabilis Medicines Inc. shares jumped as much as 67% in its trading debut, after the company raised nearly $745 million in an upsized US initial public offering that priced above its marketed range and a private placement.
1 points, 0 comments on Hacker News
Parabilis Medicines Inc. , a clinical-stage cancer drug developer, raised nearly $745 million in an upsized US initial public offering that priced above its marketed range, and a private placement.
Nature, Published online: 10 June 2026; doi:10. 1038/d41586-026-01626-1 By combining chemistry and biology with AI modelling, Layla Hosseini-Gerami is finding and reviving therapeutics with ‘huge potential’.